Market Access News | pharmaphorum

News

NICE finalises support for CSL's HAE therapy Andembry

CSL Behring's Andembry can be used to prevent recurrent attacks of HAE by the NHS, following finalised guidance from reimbursement authority NICE.

News

Boehringer bags FDA okay for new pulmonary fibrosis drug

Boehringer's successor to blockbuster IPF therapy Ofev has been approved by the FDA as Jascayd, but will the new drug be a commercial success?

News

Acting CDC director says MMR jabs should be split

The acting director of the CDC, Jim O’Neill, has been sharply criticised after saying the MMR vaccine should be separated into three individual shots.

News

Pills piled together in the shape of the USA

FDA pilots fast-track scheme for US-made generics

In another effort to boost domestic drug manufacturing, the FDA is piloting fast-track reviews for generics tested and made in US facilities.

News

Rocket aborts FDA filing for Fanconi gene therapy

Rocket Pharma has withdrawn a filing in the US for its experimental gene therapy for Fanconi anaemia, but may consider partnering the programme.

News

GLP-1s from Novo, Lilly 'should be first-line in obesity'

European doctors have said GLP-1 drugs are so effective in obesity that they should be the first choice drug treatment in almost all cases.

NICE finalises support for CSL's HAE therapy Andembry

Boehringer bags FDA okay for new pulmonary fibrosis drug

Acting CDC director says MMR jabs should be split

FDA pilots fast-track scheme for US-made generics

Rocket aborts FDA filing for Fanconi gene therapy

GLP-1s from Novo, Lilly 'should be first-line in obesity'

Otsuka grows in neuroplastogens with $1.225bn Transcend buy

Using AI-driven synthetic personas to take your insights fur...

News

Editor's Picks